The capital will support international expansion and recruitment as demand grows for the company grid stability technology.
"As we deliver more projects to support the global transition to Net Zero, this backing will empower us to deliver at scale, expand our commercial presence internationally, innovate further, and make a real contribution to a clean energy future."
Marbanc International has backed Solus Power to help commercialise its mobile electric vehicle charging technology.
"Our mission at Solus Power is to revolutionize the mobilization of energy. We have developed cutting-edge charging technology that will relieve the pain points of EV ownership and offer a seamless solution across all industries and sectors that want to move to more sustainable fleets without the worry of available infrastructure. We are delighted to have the support of Marbanc International who has recognized the significant value our technology can offer to our expansive potential client base and we now look ahead to commercialization of our products."
The oversubscribed EIS round will fund team expansion and international growth.
"It has been a pleasure to work with Gayle and her supportive team, and the success of our collaboration has been well illustrated with an oversubscribed investment round. Raising investment in today’s markets, for Companies at a similar stage in their development and investment cycle, is extremely difficult. Having the backing of Wealth Club and our existing investors provides the Company with a great deal of confidence, as we head into our growth stage. The success of this round will provide working capital for the Company to invest in revenue growth across our sectors, in addition to investing in our technology and platforms to scale and service our existing clients and an already healthy new business pipeline."
The Series C financing was led by KKR with participation from Hannover Digital Investments.
"The global insurance industry is a key strategic focus for KKR, and we see a real market opportunity for Vitesse to disrupt and add significant value to the industry. We are excited to partner with this proven management team to support Vitesse’s ambition of providing global insurers with unparalleled control, transparency, and efficiency for the holding and management of funds."
Parkwalk Advisors spearheaded the round to help the medical technology company prepare for human trials.
"With the support of our investors, we are on the cusp of revolutionising brain aneurysm treatment. Our team is dedicated to working with regulators, medical professionals, and industry experts to bring this product to market and address a condition impacting countless individuals worldwide."